Drug Insights

The Synapse User's Toolkit: Tips for Searching Naproxen

1 February 2024
2 min read

Naproxen is a small molecule drug that inhibits COX enzymes, with active indications including pain, gout, inflammation, ankylosing spondylitis, and juvenile arthritis. Approved in 1976 by Atnahs, the drug blocks the production of prostaglandins, which cause pain and inflammation in the body. Naproxen is commonly used to treat menstrual cramps, headaches, and muscle aches, and can be purchased over-the-counter in some countries or prescribed at higher doses for more severe conditions. However, it's important to take the drug as directed and under a healthcare professional's guidance to avoid potential side effects or drug interactions. Click on the image below to begin the exploration journey of Naproxen through the Synapse database!

图形用户界面, 应用程序, 电子邮件

描述已自动生成

You can search for the latest pharmaceutical information such as drugs, targets, patents, transactions, clinical results, etc. through the Synapse database. Come and experience it!

图形用户界面, 文本, 应用程序, 聊天或短信

描述已自动生成

Unlock the Power of Synapse: A Guide to Searching Famotidine
Drug Insights
2 min read
Unlock the Power of Synapse: A Guide to Searching Famotidine
1 February 2024
Famotidine is a medicine that helps people with stomach problems like gastritis and peptic ulcers.
Read →
Flare Therapeutics Reveals FX-909's Early-Stage Trial Design at 2024 ASCO Urologic Cancer Conference
Latest Hotspot
3 min read
Flare Therapeutics Reveals FX-909's Early-Stage Trial Design at 2024 ASCO Urologic Cancer Conference
1 February 2024
Flare Therapeutics Unveils Design for FX-909's Early-Stage Trial with Dose Increasing and Widening Approach at ASCO's 2024 Urologic Cancer Conference.
Read →
How to Effectively Search for Amoxicillin on Synapse
Drug Insights
2 min read
How to Effectively Search for Amoxicillin on Synapse
1 February 2024
Amoxicillin Trihydrate is a cell wall inhibitor drug used as an antibiotic to treat bacterial infections like bronchitis, pneumonia, urinary tract infections, and strep throat.
Read →
LAVA Therapeutics Partners with Merck & Co. for Potential Combination of LAVA-1207 and KEYTRUDA®
Latest Hotspot
3 min read
LAVA Therapeutics Partners with Merck & Co. for Potential Combination of LAVA-1207 and KEYTRUDA®
1 February 2024
LAVA Therapeutics reveals a partnership with Merck & Co., US, to assess the potential of combining LAVA-1207 with the treatment, KEYTRUDA®.
Read →
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.